DarioHealth Corp
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Da… Read more
DarioHealth Corp (DRIO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.098x
Based on the latest financial reports, DarioHealth Corp (DRIO) has a cash flow conversion efficiency ratio of -0.098x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.35 Million) by net assets ($74.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DarioHealth Corp - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how DarioHealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DarioHealth Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DarioHealth Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Century Lithium Corp.
V:LCE
|
-0.010x |
|
Hengyuan Refining Company Bhd
KLSE:4324
|
0.281x |
|
NFC Corporation
KQ:265740
|
0.036x |
|
Mobilicom Limited American Depositary Shares
NASDAQ:MOB
|
-0.330x |
|
Kraft Bank Asa
OL:KRAB
|
0.460x |
|
GoldMoney Inc
PINK:XAUMF
|
0.108x |
|
Allied Telesis Holdings K.K
OTCGREY:ATSKF
|
N/A |
|
Western Uranium & Vanadium Corp
OTCQX:WSTRF
|
-0.044x |
Annual Cash Flow Conversion Efficiency for DarioHealth Corp (2012–2024)
The table below shows the annual cash flow conversion efficiency of DarioHealth Corp from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $72.02 Million | $-38.56 Million | -0.535x | -2.48% |
| 2023-12-31 | $58.14 Million | $-30.38 Million | -0.522x | +12.64% |
| 2022-12-31 | $80.00 Million | $-47.84 Million | -0.598x | -1.50% |
| 2021-12-31 | $85.55 Million | $-50.41 Million | -0.589x | +6.47% |
| 2020-12-31 | $28.15 Million | $-17.74 Million | -0.630x | +24.30% |
| 2019-12-31 | $18.89 Million | $-15.72 Million | -0.832x | +35.24% |
| 2018-12-31 | $8.93 Million | $-11.47 Million | -1.285x | +52.30% |
| 2017-12-31 | $3.94 Million | $-10.62 Million | -2.694x | -310.34% |
| 2016-12-31 | $-6.54 Million | $-8.38 Million | 1.281x | +115.86% |
| 2015-12-31 | $777.00K | $-6.28 Million | -8.079x | -338.94% |
| 2014-12-31 | $-2.54 Million | $-8.58 Million | 3.381x | -96.16% |
| 2013-12-31 | $-86.38K | $-7.60 Million | 87.979x | +3053.32% |
| 2012-12-31 | $-1.07 Million | $-2.98 Million | 2.790x | -- |